The Arcturus Defense Solutions NS-10 Neurostatic is a restricted-grade incapacitating aerosol agent classified by the GLMZ Security Regulation Board as a Category III compliance chemical — the highest category available to non-governmental security actors. The NS-10 delivers a synthetic carbamate nerve agent designated ADS-7c, which acts as a rapid acetylcholinesterase inhibitor targeting the peripheral nervous system's motor control pathways. Unlike organophosphate nerve agents, ADS-7c is engineered to operate at a dosage threshold that produces profound motor paralysis within 15–30 seconds of effective exposure while preserving consciousness and autonomic functions — the subject drops, cannot move voluntarily, but continues to breathe and remains aware. The incapacitation window is 18–35 minutes depending on body mass, augmentation level, and respiratory exposure depth.

The NS-10 is a pressurized canister weapon intended for deployment by trained Arcturus security operators in high-risk apprehension scenarios — specifically, situations where conventional compliance tools have failed or where the subject is augmented to a degree that renders impact weapons or conducted energy devices ineffective. The ADS-7c compound is effective against most augmented subjects, as peripheral motor neurons remain biological in virtually all cyberware configurations. The canister uses a directed-stream delivery system with a range of up to 4 meters, and the operator is required to wear a sealed respiratory mask during deployment, as secondary exposure through ambient air is possible in enclosed spaces.

The NS-10 carries a substantial lethality caveat: subjects with compromised respiratory function, certain cardiac augmentations, or pre-existing autonomic nervous system conditions may experience severe adverse reactions including respiratory depression and cardiac arrhythmia. Arcturus's own field deployment guidelines require pre-deployment medical screening of subjects where possible — a requirement widely acknowledged as operationally impractical in real security scenarios. Multiple deaths attributed to NS-10 exposure have been documented in GLMZ civil rights filings, though Arcturus has successfully contested liability in each case.